The needle-free injection with ZENEO® Methrotrexate produces similar blood levels to the current injectable formulation Study data an important milestone in the development of CROSSJECT's portfolio of ...
EWING, N.J.--(BUSINESS WIRE)-- Antares Pharma, Inc. (NAS: ATRS) today announced positive results from an open-label, randomized, crossover study comparing the systemic availability of MTX Medi-Jet to ...
Oil prices steadied on Thursday after falling more than 1% the previous day because of a build in U.S. gasoline and diesel inventories and cuts to Saudi Arabia's July prices for Asia.
Antares Pharma, Inc. announced that the first patient has been dosed in a clinical study evaluating the Vibex MTX product which is being developed for the treatment of rheumatoid arthritis. The ...
Methotrexate, sold under the brand name Methoblastin, is an antifolate drug, which means it inhibits the activation of folic acid in the body. It is taken once per week to treat a range of conditions.
Leflunomide and methotrexate are prescription drugs used to treat rheumatoid arthritis (RA). Methotrexate is also used to treat certain other conditions, including psoriasis. This article explains the ...
CROSSJECT (ISIN: FR0011716265; Mnémo: ALCJ), the creator of ZENEO®, a needle free injection system, announces the similarity between the ZENEO® Methotrexate needle-free injection system and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results